Health · Rwanda
African Medicines Agency Inaugurates Seven Technical Expert Committees in Kigali
The African Medicines Agency has swearing-in ceremonies for seven technical expert committees in Kigali, a step in building its scientific capacity. The African Union body aims to harmonise medicine regulation across the continent, tackle falsified drugs and support local pharmaceutical production.
The African Medicines Agency (AMA) has inaugurated its technical committees in Kigali, Rwanda, where the agency is headquartered. Seven expert committees were sworn in on Monday 26 October, in what is described as a key step in building the agency's scientific expertise.
The AMA is an African Union agency created by treaty in 2019 and operational since October 2025. It aims to strengthen and harmonise the regulation of medicines and other medical products across the continent. The committees cover areas including the evaluation of vaccines and biological products, the oversight of clinical trials, and medical devices and emerging diagnostic technologies.
Their tasks include assessing medical data, inspecting manufacturing sites, and producing scientific reports and recommendations to guide the regulatory authorities of the agency's member countries.
Delese Mimi Darko, the agency's director general, said the inauguration was about putting in place the scientific structures that will allow the AMA to fulfil its mandate and support regulatory decisions across the continent. She said the experts' knowledge, judgement and integrity would determine the credibility of the agency's work. She also stressed that the AMA is not meant to replace national authorities or remove their sovereign responsibilities, but to bring experts together, coordinate rigorous scientific work and build trust in shared regulatory processes.
Among its priorities are combating falsified medicines and harmonising regulations to encourage pharmaceutical production in Africa. According to the World Health Organization, the continent imports close to 99% of its vaccines and more than 70% of its medicines.
Michel Sidibé, the African Union's special envoy for the AMA, said harmonised standards could simplify fragmented markets. He argued that 55 separate markets limit the capacity to produce and invest at scale, and that common rules could allow regional centres of excellence for manufacturing rather than duplicate production units in every country.